25 Jul 2023 --- Johnson & Johnson announced its intention to split-off at least 80.1% of the shares of Kenvue through an exchange offer. Kenvue, formerly Johnson & Johnson’s Consumer Health business, completed its initial public offering in May 2023. “The separation of Kenvue further sharpens Johnson & Johnson’s focus on transformational innovation specifically in Pharmaceutical and MedTech,” said Joaquin Duato, chairman and CEO at Johnson & Johnson.
